SEC Form 4 · accession 0001209191-15-050992
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Gillis
Director
Period of report
Jun 4, 2015
Accepted (ET)
Jun 8, 2015 · 4:05 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $184.98 | Jun 4, 2015 | A | 7,500 | A | — | Jun 4, 2025 | Common Stock | 7,500 | 7,500 | D |
Explanation of responses
- F1This option vests 100% on the earlier of June 4, 2016, or the date of the next annual meeting of stockholders.